. . . . . . . . . "\"Patients should not be treated with epirubicin hydrochloride injection if they have any of the following conditions: * cardiomyopathy and/or heart failure, recent myocardial infarction or severe arrhythmias [see Warnings and Precautions (5.3 * Previous treatment with maximum cumulative dose of anthracyclines [see Warnings and Precautions (5)] . * Hypersensitivity to epirubicin hydrochloride, other anthracyclines, or anthracenediones [see Adverse Reactions (6.2)]. Patients should not be treated with epirubicin hydrochloride injection if they have any of the following conditions: baseline neutrophil count < 1500 cells/mm 3; (4).\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "cfZWQTQiNlk6ICPV2Q7GO9Lf1V0GGDwZIIfflMKG2X0C6xNpWaAcfG0GObHXJEx8GCPjb9++yJNWuCsZ9awpjOWObcBRkcqn7/xrKlSsNj23DQDDstVh9ThhBx2aH6hAlkKQnkMWzcnsRAFxtQQwahdUDBANKr8hdUb2BaxpUBg=" . . "2021-08-25T13:54:02.882+02:00"^^ . . . . .